Clinical Trials for Hummingbird Bioscience

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hummingbird Bioscience

Clinical Trials (4)

NCT06956690
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
PHASE1/PHASE2Recruiting
180 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2027
3 conditions1 sponsor6 locations
NCT05910827
Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers
PHASE1/PHASE2Recruiting
98 participants
Started: Feb 5, 2024 · Completed: Mar 1, 2026
5 conditions2 sponsors20 locations
NCT05919537
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
PHASE1Active, not recruiting
68 participants
Started: Sep 6, 2023 · Completed: Mar 1, 2031
4 conditions1 sponsor5 locations
NCT05057013
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
PHASE1/PHASE2Active, not recruiting
81 participants
Started: Nov 10, 2021 · Completed: Nov 30, 2025
14 conditions2 sponsors4 locations